Publication Listing for the MeSH term Head and neck cancer. Found 9 abstracts

Eze N, Lee JW, Yang DH, Zhu F, Neumeister V, Sandoval-Schaefer T, Mehra R, Ridge JA, Forastiere A, Chung CH, Burtness B. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. Oral Oncol. 2019 Apr;91:69-78.   PMCID: PMC6855599

Liu JC, Bhayani M, Kuchta K, Galloway T, Fundakowski C. Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation. Oral Oncol. 2019 Jan;88:131-6.

Jamal N, Ebersole B, Erman A, Chhetri D. Maximizing Functional Outcomes in Head and Neck Cancer Survivors: Assessment and Rehabilitation. Otolaryngologic clinics of North America. 2017 Aug;50(4):837-52.

Longacre ML, Galloway TJ, Parvanta CF, Fang CY. Medical Communication-related Informational Need and Resource Preferences Among Family Caregivers for Head and Neck Cancer Patients. Journal of cancer education : the official journal of the American Association for Cancer Education. 2015 Dec;30(4):786-91.

Longacre ML, Galloway TJ, Parvanta CF, Fang CY. Medical Communication-related Informational Need and Resource Preferences Among Family Caregivers for Head and Neck Cancer Patients. J Cancer Educ. 2015 Jan;.

Martin JM, Galloway TJ. Evaluation and Management of Head and Neck Squamous Cell Carcinoma of Unknown Primary. Surg Oncol Clin N Am. 2015 Jul;24(3):579-91.

Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral Oncol. 2015 Nov;51(11):1034-40.

Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ, Expert Panel Radiation O. ACR appropriateness criteria (R) adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncology. 2011 Jul;47(7):554-9.   PMCID: not NIH funded

Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatln and paclitaxel chemotherapy from two prospective phase I and II studies. Head and Neck. 2005 Jan;27(5):406-14.

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Head and neck cancer Squamous cell carcinoma Caregiving Information seeking Pten chemoradiotherapy head and neck Hyperfractionated postoperative radiation-therapy Unknown primary chemotherapy Dysphagia Survivorship Chemoradiation locally advanced head Post-operative radiotherapy head and neck Hpv Oropharynx cancer randomized trial p16 prospective Radiation therapy Radiation Complication Post-operative cancer node-positive head Treatment Adjuvant head and neck radiotherapy Neoplasm metastasis Appropriateness criteria Biomarkers Morbidity Dysphonia Surgery oral tongue Cetuximab Chemoradiotherapy surgery margins Chemotherapy Growth rate Reirradiation